ISO Certification:

22nd September 2014:

We are pleased to announce that we have recently been certified to ISO13485 and ISO9001 with UL as the accreditation body.

You can download the certificates here: ISO 9001 and ISO 13485

Fibralign Corporation voted MedTech Innovator! 13 June 2014


The second place winner, Francis Lamont Innovations (FLI), won a $25,000 cash prize provided by JJDC.


Fibralign Corporation is the winner of the 2014 MedTech Innovator competition held during the 22nd Annual Medical Device Conference, hosted by law firm Wilson Sonsini Goodrich & Rosati. As the first place winner, Fibralign won prizes valued at $150,000, including $100,000 in cash provided by RCT Ventures, $25,000 in cash provided by Johnson & Johnson Development Corporationand $25,000 worth of state-of-the-art lab space at Janssen Labs.

The second place winner, Francis Lamont Innovations (FLI), won a $25,000 cash prize provided by JJDC. 


Medilink Awards Recognise the Best in UK Healthcare

FLi Medical Innovations - Recent Winners of "Start-up of the Year" in the national Healthcare Business Awards"

04 April 2014

The finest of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2014 Medilink UK Healthcare Business Awards.

Winner of the Nabarro LLP Start-up Award was Derbyshire-based FLi Medical Innovations, for 'FLOTE' - its novel piece of surgical equipment which assists surgeons in an approach for Total Hip Replacement, known as the ‘Direct Anterior Approach’. Independent assessments have indicated an annual saving to the NHS of over £300m if this technology is widely adopted.

The Medilink UK Awards, this year held at the Med-Tech Innovation Expo, at the Ricoh Arena, Coventry, is an annual event that celebrates cutting edge technologies, outstanding business achievements and international successes across the UK's Life Sciences sector.

Winners from five categories – Start-up, Innovation, Partnership with the NHS, Export Achievement and Outstanding Achievement - were honoured at the prestigious event.

The Awards was hosted at the end of the first day of the exhibition, as part of the Medical Device Manufacturing Conference, with leading professionals from the Life Sciences sector, UK government, research institutes and overseas organisations in attendance.

Gary Stapleton, Medilink UK's new Chairman and Business Director of 3M Health Care Business Group, West Europe, said: “We are proud to celebrate the considerable achievements of companies who have continued to push the boundaries of healthcare innovation for the benefit of business, healthcare systems and most importantly the patient.

"I would like to extend a massive congratulations to all of our winners and shortlisted companies. Their achievements should give us great encouragement for the future of our industry."

The nominees for the awards were derived from the regional awards which were selected by Medilink's network across the UK.

Winner of the Nabarro LLP Start-up Award was Derbyshire-based FLi Medical Innovations, for its novel piece of surgical equipment which assists surgeons in an approach for Total Hip Replacement, known as the ‘Direct Anterior Approach’. Independent assessments have indicated an annual saving to the NHS of over £300m if this technology is widely adopted.



RCT Ventures Announces FLI Medical Innovations Wins "MedTech Idol" at IN3 Summit

TUCSON, Ariz.--()--RCT Ventures, an investment program of Research Corporation Technologies focused on early-stage biomedical companies, announced that FLI Medical Innovations is the winner of the MedTech Idol Qualifying Round at IN3 Summit. Unlike other venture competitions, MedTech Idol allows the audience to choose the winner.

“MedTech Idol was the highlight of this year's IN3 meeting”

The final phase of the competition took place live on-stage during Elsevier Business Intelligence's (EBI) Investment In Innovation (IN3) Medical Device 360° Summit on October 17 in San Francisco. "MedTech Idol was the highlight of this year's IN3 meeting,” said David Cassak, EBI’s VP of Content. "Not only is it a fun and engaging event, it captures nicely the creativity and initiative alive in the medical device start-up world and showcases some truly ingenious technologies just coming out of the gate."

The Qualifying Round for MedTech Idol 2014 began in September, when 51 early-stage medical device companies submitted their plans. An independent panel of investor judges reviewed the entries to select the MedTech Idol Top 10. The judges included Christopher P. Martin, President, RCT Ventures; Paul Grand, Managing Director, RCT Ventures; Ned Scheetz, Founder & Managing Director, Aphelion Capital; and Renee C. Ryan, Vice President, Venture Investments, Johnson & Johnson Development Corporation (JJDC). The competition was produced by RCT Ventures and Grand served as the event’s master of ceremonies.

"Our MedTech Idol 2013 event was so successful at identifying high-quality early-stage MedTech opportunities that we decided to expand it to include qualifying rounds leading up to the Final Round at MedTech Idol 2014", said Grand. "The IN3 Summit was a great venue for our first qualifying round, as it is well-attended by industry professionals and investors actively investing in early-stage MedTech."

After reviewing the 51 entries, the judges selected 10 companies to participate in the second phase of the competition, during which each was tasked with producing a one-minute video. The videos were used to select four companies to compete live on-stage during the IN3 Summit in front of an audience of investors and medical device industry professionals. The audience then used their mobile devices to choose the winner, which was FLI Medical Innovations. FLI's primary product is a novel medical device, the Francis Lamont Orthopaedic Table Extension (FLOTE), designed to assist surgeons in direct anterior hip replacement surgery.

FLI will now compete in the MedTech Idol 2014 Final Round, which will be held in mid-2014 during the 22nd Annual Medical Device Conference, hosted by law firm Wilson Sonsini Goodrich & Rosati. EBI sponsored the prize, which was designed to provide wide exposure for the winner. FLI will get a presenting slot at an upcoming IN3 Medical Device conference, and the company will be profiled in an upcoming issue of Elsevier's monthly magazine START-UP: The Review of Emerging Medical Ventures.

"Short of actually having proven success with your innovation, there is nothing more revealing, challenging and ultimately more satisfying than being judged by your unbiased peers – this is the true value of MedTech Idol to any entrepreneur," said Malcolm Wootton, CEO of FLi Medical Innovations.

For detailed information on each of the MedTech Idol Top 10 companies, see

Hip surgery assist device wins AdvaMed scholarship | On Call

September 11, 2013 by Arezu Sarvestani

RCT BioVentures names Francis Lamont Innovations its scholarship contest winner, handing the startup an all-expenses-paid trip to AdvaMed's 2013 conference in Washington, D.C.

MassDevice On Call

MASSDEVICE ON CALL — Medical device startup Francis Lamont Innovations took home the grand prize in RCT BioVentures' scholarship sweepstakes, landing a trip to AdvaMed's 2013 medtech industry conference and a chance to present its technology in front of an audience of some of the biggest players on the field.

Francis Lamont is developing a novel device that helps orthopedic surgeons perform total hip replacements. The Francis Lamont Orthopaedic Table Extension, or FLOTE, device attaches to the end of any standard operating table and helps to control the position of the patient's leg during surgery.

PRESS RELEASE Friday 14th June 2013

Francis Lamont Innovations triumphs in Medilink East Midlands Business Awards

Derbyshire company Francis Lamont Innovations (FLi) has walked away with the Start up award in this year’s Medilink East Midlands Business Competition. The Hathersage-based company collected the prize at the Innovation Day awards dinner held last night at the Radisson Blu Hotel, East Midlands Airport.

Established in 2011, Fli Medical Innovations has been recognised for the significant early sales interest in ‘FLOTE’, a novel piece of surgical equipment to aid total hip replacement. The company has filed an international patent application, has sold and shipped 30 devices to France in the last 6 months and is also in discussion with customers in Germany, Switzerland, Australia and the US. Sales in excess of £4 million are anticipated by 2015.

Company founder, Malcolm Wootton, said: We're honoured and flattered to have won this award against, what looked like to us, very competent fellow finalists. It's a small but significant reward for the hard work of our tiny but dedicated team. I hope that, with the continued support of Medilink and some action from the local AHSN, this will help to raise our UK profile to the levels we have achieved overseas in the past 18 months.”

The Start up Award is sponsored by BioCity Nottingham. Director Toby Reid said: “Francis Lamont topped a shortlist of very impressive candidates for the start-up award. The progress they have made in product development and early stage sales in a short period of time is remarkable and so we were delighted to see them win this category.”

Speaking after the awards were announced, Dr Darren Clark, Chief Executive of Medilink East Midlands commented: “Francis Lamont Innovations impressed the award judges with the early commercial impact of the FLOTE equipment. Whilst design and innovation are commendable, it is the ability to attract international interest and sales which set this start up company apart. We congratulate them on such early success in a highly complex and competitive environment.”

Francis Lamont Innovations is automatically entered into the Medilink UK national awards which will take place in early 2014.

The Awards ceremony took place on the evening following the Medilink East Midlands Innovation Conference, which was supported by the Healthcare and Bioscience iNet project (part-financed by the European Regional Development Fund (ERDF). . This year’s conference theme, ‘Revolutionising Healthcare –What part will you play?’ attracted over 200 of the region’s leading businesses and academics in the sector.